Issue

Vol. 65 No. 3: Issue 3

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Investigation of cytotoxic, genotoxic, and apoptotic effects of curcumin on glioma cells

https://doi.org/10.14715/cmb/2019.65.3.15
Mehmet Hakan Seyithanoğlu
Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
Anas Abdallah
Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
Serkan Kitiş
Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
Eray Metin Güler
Department of Biochemistry, Bezmialem Vakif University, Istanbul, Turkey
Abdurrahim Koçyiğit
Department of Biochemistry, Bezmialem Vakif University, Istanbul, Turkey
Tolga Turan Dündar
Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey
Meliha Gündağ Papaker
Department of Neurosurgery, Bezmialem Vakif University, Istanbul, Turkey

Corresponding Author(s) : Anas Abdallah

abdallahanas@hotmail.com

Cellular and Molecular Biology, Vol. 65 No. 3: Issue 3

Abstract

Glioblastoma is a malignant tumor of the brain. The treatment of this tumor is still a challenge. Curcumin has been shown to have therapeutic effects when used to treat malignant diseases. However, the molecular mechanisms of its action are not fully elucidated. We hypothesized that reactive oxygen species (ROS) have a key role in curcumin-induced DNA damage, apoptosis, and cell death. To test our hypothesis, cytotoxic, genotoxic, apoptotic, and ROS-generating effects, as well as mitochondrial membrane potentials of curcumin on rat glioma cells (C-6) and normal fibroblastic cells (L-929) were investigated. We examined concentration-dependent cytotoxic, genotoxic, apoptotic, and ROS generating effects of curcumin at C-6 cells and L-929 cells. The cells were incubated with different doses of curcumin (10-100 µM) for 24 hours. Higher doses of curcumin resulted in greater cellular death of cancer than of normal cells at higher concentrations. Curcumin also induced ROS generation in cancer than normal cells in a concentration-dependent manner. Our results showed that curcumin-induced DNA damage in a dose-dependent manner (p < 0.001). At high curcumin concentration such as 80 µM, the proportions of live cells in cancer and normal cell lines were 11.5 and 44.3, respectively. The higher doses of curcumin resulted in greater apoptosis in cancer than normal cells.This in vitro study provided clear evidence that curcumin induced DNA damage and apoptosis. Cytotoxicity may be due to its pro-oxidant activity in a dose-dependent manner in cancer and normal cells. These activities were higher in cancer cells.

Keywords

Glioblastoma Curcumin Antioxidants Apoptosis Cytotoxicity Genotoxic Activity.
Seyithanoğlu, M. H., Abdallah, A., Kitiş, S., Güler, E. M., Koçyiğit, A., Dündar, T. T., & Gündağ Papaker, M. (2019). Investigation of cytotoxic, genotoxic, and apoptotic effects of curcumin on glioma cells. Cellular and Molecular Biology, 65(3), 101–108. https://doi.org/10.14715/cmb/2019.65.3.15
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. - Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci 2014;15(7):455–65.
  2. - Norden AD, Drappatz J, Wen PY. Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol 2009;5(11):610–20.
  3. - Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012;483(7390):479–83.
  4. - Stedt H, Samaranayake H, Pikkarainen J, Maatta AM, Alasaareia L, Airenne K et al. Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide. Gene Ther 2013;20(12):1165–71.
  5. - Tan B, Li Y, Zhao Q, Fan L, Liu Y, Wang D, et al. Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway. Cancer Gene Ther 2014;21(12):526–31.
  6. - Xi G, Hayes E, Lewis R, Ichi S, Mania-Farnell B, Shim K, et al. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro. Oncogene 2016;35(2):241–50.
  7. - Lopez-Lazaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008;52(Suppl 1):103–27.
  8. - Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23(1A):363–98.
  9. - Eckert RL, Crish JF, Efimova T, Balasubramanian S. Antioxidants regulate normal human keratinocyte differentiation. Biochem Pharmacol 2004;68(6):1125–31.
  10. - Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 2002;11(6):535–40.
  11. - Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G et al. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 2006;66(2):613–21.
  12. - Ray A. Cancer preventive role of selected dietary factors. Indian J Cancer 2005;42(1):15–24.
  13. - Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Bio 2007;595: 1–75.
  14. - Hsu YC, Weng HC, Lin S, Chien YW. Curcuminoids cellular uptake by human primary colon cancer cells as quantitated by a sensitive Hplc assay and its relation with the inhibition of proliferation and apoptosis. J Agric Food Chem 2007;55(20):8213–22.
  15. - Lin YT, Wang LF, Hsu YC. Curcuminoids suppress the growth of pharynx and nasopharyngeal carcinoma cells through induced apoptosis, J Agric Food Chem 2009;57(9):3765–70.
  16. - Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175(1):184–91.
  17. - Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P et al. Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis 2003;18(1):45–51.
  18. - McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, et al. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods cell boil 1995;46:153–85.
  19. - Rottenberg H, Wu S. Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells. Biochim Biophys Acta (BBA)-Molecular Cell Research 1998;1404(3):393–404.
  20. - Senft C, Franz K, Ulrich CT, Bink A, Szelenyi A, Gasser T, et al. Low field intraoperative MRI-guided surgery of gliomas: a single center experience. Clin Neurol Neurosurg 2010;112(3):237–43.
  21. - Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7(5):392–401.
  22. - Tosuner Z, Geçer Mí–, Hatiboğlu MA, Abdallah A, Turna S. BRAF V600E mutation and BRAF VE1 immunoexpression profiles in different types of glioblastoma. Oncol Lett 2018;16(2):2402–8.
  23. - Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008;269(2):199–225.
  24. - Wang Y, Ying X, Xu H, Yan H, Li X, Tang H. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. Int J Nanomedicine 2017;12:1369–84.
  25. - Falke J, Parkkinen J, Vaahtera L, Hulsbergen-van de Kaa CA, Oosterwijk E, Witjes JA. Curcumin as treatment for bladder cancer: A preclinical study of cyclodextrin-curcumin complex and BCG as intravesical treatment in an orthotopic bladder cancer rat model. Biomed Res Int 2018;9634902.
  26. - Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 2009;11(3):495–510.
  27. - Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 2007;102(2):522–38.
  28. - Hartojo W, Silvers AL, Thomas DG, Serder CW, Lin L, Rao H, et al. Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol 2010;3(2):99–108.
  29. - Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, et al. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 2009;125(9):2187–97.
  30. - Wang HJ, Yang ZX., Dai XT, Chen YF, Yang HP, Zhou XD. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Apoptosis 2017;22(9):1157–68.
  31. - Maiti P, Al-Gharaibeh A, Kolli N, Dunbar GL. Solid lipid curcumin particles induce more DNA fragmentation and cell death in cultured human glioblastoma cells than does natural curcumin. Oxidative Medicine and Cellular Longevity 2017:9656719.
  32. - Mukherjee S, Fried A, Hussaini R, White R, Baidoo J, Yalamanchi S, et al. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. Journal of experimental & clinical cancer research 2018;37(1):168.
  33. - Limtrakul P. Curcumin as chemosensitizer. Adv Exp Med Biol 2007;595: 269–300.
  34. - Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, et al. Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways. Onco Targets Ther 2017;10:5471-82.
  35. - Huang TY, Hsu CW, Chang WC, Wang MY, Wu JF, Hsu YC. Demethoxycurcumin retards cell growth and induces apoptosis in human brain malignant glioma GBM 8401 cells. Evidence-Based Complementary and Alternative Medicine 2012;396573.
  36. - Dairam A, Limson JL, Watkins GM, Antunes E, Dava S. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male wistar rats. J Agric Food Chem 2007;55(3):1039–44.
  37. - Cocorocchio M, Baldwin AJ, Stewart B, Kim L, Harwood AJ, Thompson CRL, et al. Curcumin and derivatives function through protein phosphatase 2A and presenilin orthologues in Dictyostelium discoideum. Disease Models & Mechanisms 2018;11:dmm032375.
  38. - Ahmed T, Gilani AH. A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Aβ plus ibotenic acid-infused rat model of Alzheimer's disease, Brain Res 2010;1400:1–18.
  39. - Chen MJ, Lin YW, Cheng YM, Wu JF, Hsu YC. Early experimental results of colorectal carcinoma chemotherapeutics by liposomal curcuminoids. Dig J Nanomater Biostruct 2011;6(3):1445–56.
  40. - Zhongfa L, Chiu M, Wang J, Chen W, Yen W, Patty FH, et al. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother. Pharmacol 2012;69(3):679–89.
  41. - Purkayastha S, Berliner A, Fernando SS, Ranasinghe B, Ray I, Tarig H, et al. Curcumin blocks brain tumor formation. Brain Res 2009;1266:130–8.
  42. - Zhao J, Yu S, Zheng W, Feng G, Luo G, Wang L et al. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res 2010;35(3):174–9.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 1029 Download : 502